Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kempf Dominique"'
Autor:
Uluckan, Özge, Bruno, Sandro, Wang, Yichen, Wack, Nathalie, Wilzopolski, Jenny, Goetschy, Jean-Francois, Delucis-Bronn, Corinne, Urban, Beatrice, Fehlmann, Dominique, Stark, Holger, Hauchard, Alice, Roussel, Elsa, Kempf, Dominique, Kaupmann, Klemens, Raulf, Friedrich, Bäumer, Wolfgang, Röhn, Till A., Zerwes, Hans Günter
Publikováno v:
In European Journal of Pharmacology 15 April 2023 945
Publikováno v:
European Journal of Haematology. May2016, Vol. 96 Issue 5, p502-506. 5p.
Autor:
Griffin D. James, Fendrich Gabriele, Manley W. Paul, Cowan-Jacob Sandra, Furet Pascal, Fabbro Doriano, Weisberg Ellen, Goutte Gerard, Juergen Mestan, Kempf Dominique, Gaugler Markus
Publikováno v:
Blood. 104:1978-1978
Imatinib mesylate (Gleevec®, Novartis Pharma AG), an inhibitor of the c-Abl/Bcr-Abl, c-Kit, and PDGFR kinases, is an effective therapy for CML, GIST and HES. However, advanced stage CML and Ph+ ALL patients frequently relapse due to the development
Autor:
Butz, Nicole1, Ruetz, Stephan1, Natt, Francois2, Hall, Jonathan2, Weiler, Jan2, Mestan, Jürgen1, Ducarre, Monique1, Grossenbacher, Rita1, Hauser, Patrick1, Kempf, Dominique1, Hofmann, Francesco1 francesco.hofmann@pharma.novartis.com
Publikováno v:
Experimental Cell Research. Feb2005, Vol. 303 Issue 2, p482-493. 12p.
Autor:
Butz N; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Disease Area Oncology, CH-4002 Basel, Switzerland., Ruetz S, Natt F, Hall J, Weiler J, Mestan J, Ducarre M, Grossenbacher R, Hauser P, Kempf D, Hofmann F
Publikováno v:
Experimental cell research [Exp Cell Res] 2005 Feb 15; Vol. 303 (2), pp. 482-93.